Latest news
FDA Accepts SL1009 Resubmission for PDCD, Sets December PDUFA Date - NeurologyLiveNeurologyLive · Tue, 04 Aug 2026 23:15:37 GMTSaol Therapeutics Announces the Acceptance of Resubmission of SL1009 (DCA) by the FDA with PDUFA Date of Dec. 30, 2026 - PR NewswirePR Newswire · Tue, 28 Jul 2026 13:40:00 GMT